It should be noted that there was a reduction in the proportion of patients with AKI receiving ACEi/ARB, NSAIDs and multiple risk factor drug classes prior to AKI onset between cycles 2 and 3, although this did not reach statistical significance.
← all excerpts
Reducing incidence of postoperative acute kidney injury in trauma and orthopaedics patients: a quality improvement project.
1
—
—